DK2929880T3 - Terapeutisk middel til sygdom baseret på hæmmende effekt af makrofag-migrationshæmmende faktor - Google Patents

Terapeutisk middel til sygdom baseret på hæmmende effekt af makrofag-migrationshæmmende faktor

Info

Publication number
DK2929880T3
DK2929880T3 DK14826811.3T DK14826811T DK2929880T3 DK 2929880 T3 DK2929880 T3 DK 2929880T3 DK 14826811 T DK14826811 T DK 14826811T DK 2929880 T3 DK2929880 T3 DK 2929880T3
Authority
DK
Denmark
Prior art keywords
therapeutic agent
disease based
macrophage migration
inhibitory effect
inhibitory
Prior art date
Application number
DK14826811.3T
Other languages
English (en)
Inventor
Keiichi Tanaka
Kimiko Morimoto
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Application granted granted Critical
Publication of DK2929880T3 publication Critical patent/DK2929880T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
DK14826811.3T 2013-07-18 2014-07-17 Terapeutisk middel til sygdom baseret på hæmmende effekt af makrofag-migrationshæmmende faktor DK2929880T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013149690 2013-07-18
PCT/JP2014/069026 WO2015008827A1 (ja) 2013-07-18 2014-07-17 マクロファージ遊走阻止因子の阻害作用に基づく疾患の治療剤

Publications (1)

Publication Number Publication Date
DK2929880T3 true DK2929880T3 (da) 2017-01-02

Family

ID=52346269

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14826811.3T DK2929880T3 (da) 2013-07-18 2014-07-17 Terapeutisk middel til sygdom baseret på hæmmende effekt af makrofag-migrationshæmmende faktor
DK16169414.6T DK3078372T3 (da) 2013-07-18 2014-07-17 Terapeutisk middel mod sygdom på basis af hæmmende virkning af makrofag-migrationshæmmende faktor

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK16169414.6T DK3078372T3 (da) 2013-07-18 2014-07-17 Terapeutisk middel mod sygdom på basis af hæmmende virkning af makrofag-migrationshæmmende faktor

Country Status (23)

Country Link
US (3) US20150353519A1 (da)
EP (2) EP2929880B1 (da)
JP (2) JP5802868B2 (da)
CN (1) CN105407887B (da)
AU (1) AU2014291149B2 (da)
CA (1) CA2918325C (da)
CY (2) CY1118140T1 (da)
DK (2) DK2929880T3 (da)
ES (2) ES2642440T3 (da)
HK (1) HK1222556A1 (da)
HR (2) HRP20161317T1 (da)
HU (2) HUE034661T2 (da)
IL (1) IL243550B (da)
LT (2) LT3078372T (da)
NO (1) NO3078372T3 (da)
PL (2) PL3078372T3 (da)
PT (2) PT2929880T (da)
RS (2) RS56489B1 (da)
RU (2) RU2641301C2 (da)
SI (2) SI3078372T1 (da)
SM (1) SMT201700080B (da)
TW (1) TWI603965B (da)
WO (1) WO2015008827A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6901571B2 (ja) * 2017-01-26 2021-07-14 四川瀛瑞医薬科技有限公司Sichuan Yingrui Pharmaceutical Technology Company ナノ炭素−鉄複合システム及びその組成物、調製方法並びに使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753725B2 (ja) * 1987-10-08 1995-06-07 富山化学工業株式会社 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
JP3521145B2 (ja) * 1993-04-09 2004-04-19 富山化学工業株式会社 免疫調節剤,細胞接着阻害剤および自己免疫疾患の治療・予防剤
EP0868598B1 (de) * 1995-12-21 1999-10-27 Siemens Aktiengesellschaft Luftansaugvorrichtung mit variabler saugrohrlänge für eine brennkraftmaschine
DE10044091A1 (de) * 2000-09-07 2002-04-04 Merck Patent Gmbh Chromanonderivate
GB0507696D0 (en) * 2005-04-15 2005-05-25 Novartis Ag Organic compounds
GB0507695D0 (en) 2005-04-15 2005-05-25 Novartis Ag Organic compounds
EP1940382A2 (en) * 2005-10-07 2008-07-09 Aditech Pharma AB Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders
WO2013031831A1 (ja) 2011-08-30 2013-03-07 富山化学工業株式会社 関節リウマチなどの自己免疫疾患の治療の改善方法

Also Published As

Publication number Publication date
LT2929880T (lt) 2016-11-25
EP2929880B1 (en) 2016-09-14
WO2015008827A1 (ja) 2015-01-22
JP2016034953A (ja) 2016-03-17
JPWO2015008827A1 (ja) 2017-03-02
CA2918325A1 (en) 2015-01-22
EP3078372B1 (en) 2017-09-13
TWI603965B (zh) 2017-11-01
DK3078372T3 (da) 2017-10-16
RU2017131951A (ru) 2019-02-06
RS55394B1 (sr) 2017-04-28
ES2642440T3 (es) 2017-11-16
CA2918325C (en) 2018-06-26
CN105407887A (zh) 2016-03-16
HUE029800T2 (en) 2017-04-28
IL243550A0 (en) 2016-02-29
PL3078372T3 (pl) 2018-02-28
HUE034661T2 (en) 2018-02-28
EP3078372A1 (en) 2016-10-12
HK1222556A1 (zh) 2017-07-07
NO3078372T3 (da) 2018-02-10
HRP20161317T1 (hr) 2016-12-16
PT3078372T (pt) 2017-10-18
EP2929880A4 (en) 2015-10-14
JP5802868B2 (ja) 2015-11-04
SI2929880T1 (sl) 2016-12-30
US20160228406A1 (en) 2016-08-11
LT3078372T (lt) 2017-11-27
RU2017131951A3 (da) 2020-12-18
CY1119496T1 (el) 2018-03-07
CN105407887B (zh) 2018-09-04
JP6060231B2 (ja) 2017-01-11
IL243550B (en) 2019-06-30
ES2593527T3 (es) 2016-12-09
RU2016105141A (ru) 2017-08-23
EP2929880A1 (en) 2015-10-14
RU2750540C2 (ru) 2021-06-29
PT2929880T (pt) 2016-11-08
US20150353519A1 (en) 2015-12-10
US9918963B2 (en) 2018-03-20
SI3078372T1 (en) 2018-01-31
PL2929880T3 (pl) 2017-03-31
TW201536764A (zh) 2015-10-01
RU2641301C2 (ru) 2018-01-17
HRP20171497T1 (hr) 2017-11-17
US20160228404A1 (en) 2016-08-11
CY1118140T1 (el) 2017-06-28
AU2014291149B2 (en) 2017-05-04
AU2014291149A1 (en) 2016-02-11
SMT201700080B (it) 2017-03-08
RS56489B1 (sr) 2018-01-31

Similar Documents

Publication Publication Date Title
DK3191144T3 (da) Medicinsk forbinding
DK2961410T3 (da) Anvendelse af pyrazolopyrimidinderivater til behandlingen af pi3k relaterede lidelser
DK3030323T3 (da) Kdm1a-inhibitorer til behandlingen af sygdom
DK2970389T3 (da) Farmaceutiske forbindelser
DK3192518T3 (da) Anti-inflammatorisk middel
DK3019166T3 (da) A Pharmaceutical Combination for the Treatment of Melanoma
DK3363428T3 (da) Perfusionsdoseringsform
DK3374497T3 (da) Modificerede makrofager til anvendelse i behandlingen af kræft
DK2974728T3 (da) Terapeutisk middel til meibomsk dysfunktion
DK3408265T3 (da) Terapeutiske forbindelser
DK2932944T3 (da) Støtteortose
DK3058344T3 (da) Fremgangsmåder til måling af carbonhydridfluiders tilsmudsningstendens
DK3096775T3 (da) SOCS-mimetika til behandling af sygdomme
DK3089778T3 (da) Ballonkateter
DK3024816T3 (da) Ppar-sparende forbindelser til behandling af metaboliske sygdomme
CL2016000616A1 (es) Compuestos heterocíclicos de n-acilimino.
DK2929880T3 (da) Terapeutisk middel til sygdom baseret på hæmmende effekt af makrofag-migrationshæmmende faktor
FI20136034A (fi) Sauna
FR3036281B1 (fr) Fauteuil roulant
ITBG20150006U1 (it) Easy braces
UA27564S (uk) Календар відривний
FI10384U1 (fi) Yhdistelmälämpöpumppu
UA28338S (uk) Медичний пристрій-шприц
UA28339S (uk) Медичний пристрій-шприц
TH1501005383A (th) องค์ประกอบลดเสียง